Clinical Trials Directory

Trials / Conditions / Advanced Gastric Adenocarcinoma

Advanced Gastric Adenocarcinoma

21 registered clinical trials studyying Advanced Gastric Adenocarcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenoc
NCT06846346
UNICANCERPhase 2
RecruitingTotal Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
NCT06028737
Ukrainian Society of Clinical OncologyPhase 2 / Phase 3
RecruitingAdding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
NCT06203600
National Cancer Institute (NCI)Phase 2 / Phase 3
RecruitingmFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastati
NCT05677490
Alliance for Clinical Trials in OncologyPhase 3
UnknownA Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control
NCT05583383
Henan Cancer HospitalN/A
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
UnknownA Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adeno
NCT04977193
Shanghai Longyao Biotechnology Inc., Ltd.EARLY_Phase 1
CompletedFirst-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC
NCT06238752
Renmin Hospital of Wuhan UniversityPhase 2
UnknownCamrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
NCT04675866
Henan Cancer HospitalN/A
Active Not RecruitingPaclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
NCT04209686
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
UnknownPD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer
NCT04174339
Fujian Cancer HospitalN/A
UnknownProspectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liq
NCT04993378
Shen Lin—
CompletedStudy of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With M
NCT02447380
Samsung Medical CenterPhase 2
UnknownClinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarci
NCT03159819
Changhai HospitalN/A
CompletedStudy of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-lin
NCT02449551
Samsung Medical CenterPhase 2
CompletedPI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma
NCT02615730
Yonsei UniversityPhase 1 / Phase 2
CompletedStudy to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary T
NCT02599324
Pharmacyclics LLC.Phase 1 / Phase 2
CompletedPhase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Seque
NCT02447406
Samsung Medical CenterPhase 1 / Phase 2
TerminatedTrial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gast
NCT02449655
Samsung Medical CenterPhase 2
CompletedStudy of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring TP53 Mu
NCT02448329
Samsung Medical CenterPhase 2
UnknownEfficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer
NCT02240524
Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityPhase 3